Scarica l'app Stockscreener
73.49
1.38%
1.00
Dopo l'orario di chiusura:
73.68
0.19
+0.26%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CVS Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$72.49
Aprire:
$72.5
Volume 24 ore:
6.03M
Relative Volume:
0.71
Capitalizzazione di mercato:
$93.49B
Reddito:
$402.11B
Utile/perdita netta:
$1.73B
Rapporto P/E:
53.12
EPS:
1.3835
Flusso di cassa netto:
$7.81B
1 W Prestazione:
+3.25%
1M Prestazione:
-10.00%
6M Prestazione:
-5.11%
1 anno Prestazione:
+7.96%
Intervallo 1D:
$72.12
$73.68
Intervallo di 1 settimana:
$69.51
$73.68
Portata 52W:
$58.35
$85.15
Cvs Health Corp Stock (CVS) Company Profile
Nome
Cvs Health Corp
Settore
Industria
Telefono
(401) 765-1500
Indirizzo
ONE CVS DR., WOONSOCKET
Compare CVS vs UNH, CI, ELV, HUM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CVS
Cvs Health Corp
|
73.49 | 93.49B | 402.11B | 1.73B | 7.81B | 1.3835 |
UNH
Unitedhealth Group Inc
|
277.26 | 251.66B | 447.57B | 12.81B | 16.08B | 13.19 |
CI
Cigna Group
|
270.02 | 71.19B | 274.88B | 6.29B | 8.39B | 22.19 |
ELV
Elevance Health Inc
|
300.74 | 66.06B | 199.13B | 5.66B | 3.17B | 25.11 |
HUM
Humana Inc
|
177.83 | 21.35B | 129.66B | 1.20B | 375.00M | 9.8083 |
Cvs Health Corp Stock (CVS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-12 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2025-10-14 | Iniziato | Goldman | Buy |
| 2025-08-18 | Aggiornamento | UBS | Neutral → Buy |
| 2025-08-14 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2025-02-13 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2025-02-12 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-30 | Aggiornamento | Edward Jones | Hold → Buy |
| 2024-12-03 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2024-11-18 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2024-10-10 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2024-10-04 | Aggiornamento | TD Cowen | Hold → Buy |
| 2024-05-30 | Iniziato | Robert W. Baird | Neutral |
| 2024-05-07 | Downgrade | TD Cowen | Buy → Hold |
| 2024-05-02 | Downgrade | UBS | Buy → Neutral |
| 2024-05-01 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2024-05-01 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-03-06 | Iniziato | Barclays | Equal Weight |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2023-12-22 | Iniziato | HSBC Securities | Buy |
| 2023-09-19 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2023-09-12 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2023-08-18 | Downgrade | Edward Jones | Buy → Hold |
| 2023-05-26 | Iniziato | Piper Sandler | Overweight |
| 2023-04-21 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-01-03 | Downgrade | Evercore ISI | Outperform → In-line |
| 2022-11-23 | Ripresa | Morgan Stanley | Overweight |
| 2022-06-17 | Iniziato | Loop Capital | Buy |
| 2022-05-27 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2022-03-29 | Downgrade | Deutsche Bank | Buy → Hold |
| 2022-02-11 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2021-12-14 | Iniziato | Goldman | Buy |
| 2021-12-01 | Iniziato | Seaport Research Partners | Buy |
| 2021-05-19 | Iniziato | Wells Fargo | Equal Weight |
| 2021-03-17 | Downgrade | Guggenheim | Buy → Neutral |
| 2021-01-08 | Aggiornamento | Jefferies | Hold → Buy |
| 2020-09-17 | Iniziato | Piper Sandler | Overweight |
| 2020-07-01 | Iniziato | SVB Leerink | Mkt Perform |
| 2020-05-14 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2019-09-27 | Ripresa | RBC Capital Mkts | Outperform |
| 2019-09-12 | Iniziato | Deutsche Bank | Buy |
| 2019-06-05 | Aggiornamento | Standpoint Research | Hold → Buy |
| 2019-04-29 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2019-04-18 | Iniziato | Guggenheim | Buy |
| 2019-04-15 | Downgrade | Oppenheimer | Outperform → Perform |
| 2019-04-10 | Reiterato | BofA/Merrill | Buy |
| 2019-03-13 | Iniziato | Bernstein | Outperform |
| 2019-02-20 | Downgrade | Wells Fargo | Outperform → Market Perform |
| 2019-01-17 | Iniziato | UBS | Buy |
| 2018-12-18 | Iniziato | Barclays | Overweight |
| 2018-11-29 | Ripresa | Goldman | Neutral |
| 2018-11-28 | Iniziato | Evercore ISI | Outperform |
| 2018-10-26 | Ripresa | Wolfe Research | Peer Perform |
| 2018-07-09 | Aggiornamento | Citigroup | Neutral → Buy |
| 2018-02-27 | Ripresa | BofA/Merrill | Buy |
| 2018-02-13 | Reiterato | Citigroup | Neutral |
Mostra tutto
Cvs Health Corp Borsa (CVS) Ultime notizie
CVS Pharmacy: Essential Retail for Health and Wellness Needs - AD HOC NEWS
If You'd Invested $100 in CVS Health (CVS) Stock 5 Years Ago, Here's How Much You'd Have Today (Spoiler: You Wouldn't Have Lost Money) - AOL.com
If You'd Invested $100 in CVS Health (CVS) Stock 5 Years Ago, Here's How Much You'd Have Today (Spoiler: You Wouldn't Have Lost Money) - The Motley Fool
CVS HEALTH Corp ($CVS) CEO 2025 Pay Revealed - Moomoo
CVS Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Toth Financial Advisory Corp Boosts Stock Position in CVS Health Corporation $CVS - MarketBeat
⚠️ HEALTH WARNING: The recall includes products sold at major retailers like Walgreens and CVS. - facebook.com
CVS Health Releases 2026 Proxy Statement - National Today
CVS class action alleges kickbacks for drug formulary access - Class Action Lawsuits
Form DEFA14A CVS HEALTH Corp - StreetInsider
[ARS] CVS HEALTH Corp SEC Filing - Stock Titan
CVS Health Corporation (CVS) stock price, news, quote and history - Yahoo Finance Singapore
CVS Health Corporation (CVS) Stock Price, News, Quote & History - Yahoo! Finance Canada
Aberdeen Group Lowers Stake in CVS Health - National Today
Aberdeen Group plc Lowers Stake in CVS Health Corporation $CVS - MarketBeat
Truist Securities reiterates Buy rating on CVS Health stock at $98 - Investing.com
CVS Pharmacy's Strategic Expansion in Digital Health and Retail Pharmacy Services Drives Long-Term I - AD HOC NEWS
CVS Health (CVS) grants options and RSUs to EVP Prem Shah - Stock Titan
CVS (CVS) CFO Brian Newman receives new stock options and RSU awards - Stock Titan
[Form 4] CVS HEALTH Corp Insider Trading Activity - Stock Titan
CVS (CVS) EVP Tilak Mandadi receives stock options, RSUs and surrenders shares for taxes - Stock Titan
CVS Health (NYSE: CVS) grants options and RSUs to top legal executive - Stock Titan
CVS (CVS) CEO Joyner receives large RSU grant and surrenders shares for taxes - Stock Titan
CVS Health (CVS) awards stock options and RSUs to its Chief Medical Officer - Stock Titan
CVS (CVS) SVP granted stock, options as 3,262 shares withheld for taxes - Stock Titan
CVS Health (NYSE: CVS) grants options and RSUs to EVP Capozzi - Stock Titan
CVS Health Corp. stock outperforms competitors on strong trading day - MarketWatch
CVS Pharmacy's Digital Health Innovations Drive Strategic Growth in North American Retail Pharmacy S - AD HOC NEWS
CVS Health Corp (CVS) Stock Price, Trades & News - GuruFocus
Omnicare enters asset purchase deal with GenieRx as stalking horse - Investing.com
Omnicare sets sale floor as rival bids stay open until April 30 - Stock Titan
CVS Health (CVS) Under Analyst Spotlight Following Proposed FTC Settlement Related to Insuling Pricing - Insider Monkey
Vaughan Nelson Investment Management L.P. Sells 17,250 Shares of CVS Health Corporation $CVS - MarketBeat
CVS Health Corporation $CVS Shares Acquired by Nisa Investment Advisors LLC - MarketBeat
Healthcare Reclaims No. 1 Spot On Americans' List Of Worries As Financial Strain Grows - Benzinga
List of 19 Acquisitions by CVS Health (Apr 2026) - Tracxn
CVS Health Corp (XSWX:CVS) Dividend - GuruFocus
CVS Health Corp Stock Operating Data - GuruFocus
CVS Health Sees Unusually High Options Volume (NYSE:CVS) - MarketBeat
CVS Health Corp. stock rises Tuesday, still underperforms market - MarketWatch
CVS Specialty delivers personalized care through 30+ Centers of Excellence - CVS Health
CVS To Increase Retail Footprint After 4 Years Of Shrinking Its Store Count - Bisnow
Nation's largest pharmacy chain set to open 60 new locations just months after retail apocalypse - The US Sun
Piper Sandler Issues Pessimistic Forecast for CVS Health (NYSE:CVS) Stock Price - MarketBeat
Piper Sandler Adjusts Price Target for CVS Health (CVS) to $99 | - gurufocus.com
CVS plans 20 pharmacy-only stores in shift toward expansion - supermarketnews.com
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields - Benzinga
Retirement Systems of Alabama Acquires 606,054 Shares of CVS Health Corporation $CVS - MarketBeat
Spire Wealth Management Has $2.09 Million Position in CVS Health Corporation $CVS - MarketBeat
CVS plans roughly 60 store openings in 2026 after years of net closures - Yahoo Finance
apricus wealth LLC Lowers Position in CVS Health Corporation $CVS - MarketBeat
Cvs Health Corp Azioni (CVS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.01%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):